Literature DB >> 12502728

Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease.

Trang T Duong1, Earl D Silverman, Martindale V Bissessar, Rae S M Yeung.   

Abstract

Kawasaki disease (KD) is a multisystem vasculitis and the leading cause of acquired heart disease in children of the developed world. Lactobacillus casei cell wall extract-induced coronary arteritis in mice mirrors KD in children. Here, we report that responses to L. casei cell wall extract possess all the hallmarks of a superantigen-mediated response: marked proliferation of naive T cells, non-classical major histocompatibility restriction with a hierarchy in the efficiency of different class II molecules to present this superantigen, a requirement for antigen presentation, but not processing, and stimulation of T cells in a non-clonal, TCR V(beta) chain-dependent fashion. This superantigenic activity directly correlates with the ability to induce coronary arteritis in mice. Taken together, our findings demonstrate that superantigenic activity in L. casei cell wall extract is responsible for induction of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502728     DOI: 10.1093/intimm/dxg007

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Endothelial Nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis.

Authors:  Yang Chen; Xiang Li; Krishna M Boini; Ashley L Pitzer; Erich Gulbins; Yang Zhang; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2014-11-15

3.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

4.  Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease.

Authors:  Cristina M Alvira; Christophe Guignabert; Yu-Mee Kim; Chihhsin Chen; Lingli Wang; Trang T Duong; Rae S M Yeung; Dean Y Li; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

6.  Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.

Authors:  A C Lau; T T Duong; S Ito; G J Wilson; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

7.  Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.

Authors:  Harutaka Katano; Seiichi Sato; Tsuyoshi Sekizuka; Akiko Kinumaki; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Shigeru Morikawa; Masayuki Saijo; Tetsuya Mizutani; Makoto Kuroda
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

8.  Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease.

Authors:  Danica J Schulte; Atilla Yilmaz; Kenichi Shimada; Michael C Fishbein; Emily L Lowe; Shuang Chen; Michelle Wong; Terence M Doherty; Thomas Lehman; Timothy R Crother; Rosalinda Sorrentino; Moshe Arditi
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

9.  The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease.

Authors:  Chisato Shimizu; Toshiaki Oharaseki; Kei Takahashi; Aubri Kottek; Alessandra Franco; Jane C Burns
Journal:  Hum Pathol       Date:  2012-09-03       Impact factor: 3.466

10.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.